Results 31 to 40 of about 3,716 (156)

Whole blood transfusion in small animals: indications and effects

open access: yesAnais da Academia Brasileira de Ciências, 2011
Transfusion therapy is a major resource that can improve the patient's capability to overcome the underlying disease. However, the effects of whole blood infusion, and how they affect the patient's outcome, are not yet clear.
Luís F Godinho-Cunha   +2 more
doaj   +1 more source

Avaliação do conhecimento sobre hemoterapia e segurança transfusional de profissionais de enfermagem Evaluation of knowledge about hemotherapy and transfusional care of nurses

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2007
Os riscos envolvidos na transfusão de sangue e hemoderivados podem ser conseqüentes de procedimentos inadequados, erros ou omissões dos profissionais responsáveis pela transfusão.
Oranice Ferreira   +3 more
doaj   +1 more source

Agências transfusionais e conformidades com a legislação hemoterápica | Hemotherapy agencies in compliance with hemotherapy legislation

open access: yesVigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia, 2016
Este estudo tem por objetivo discutir a situação de agências transfusionais do estado do Pará, Brasil, e sua relação com a legislação hemoterápica. Os dados foram coletados a partir da aplicação de questionário aos profissionais médicos, bioquímicos ...
Marineide Sousa Bastos   +1 more
doaj   +1 more source

A case series of platelet rich plasma in chronic venous ulcers

open access: yesRegenerative Therapy, 2021
Introduction: Venous ulcers are the most common type of leg wounds (80%) and the main cause is chronic venous insufficiency. Autologous platelet-rich plasma (PRP) is a potential wound healing treatment due to its great variety of growth factors.
Stephany Cares Huber   +6 more
doaj   +1 more source

Hemotherapy support in HSCT

open access: yesJOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 2023
Hemotherapy support is essential for Hematopoietic Stem Cell Transplantation (HSCT). In this article, we highlight the main points published in the 2020 SBTMO consensus and provide a brief update on the topic.
Karen De Lima Prata   +4 more
openaire   +1 more source

Autohemotherapy: A Review of the Literature.

open access: yesMedicina, 2015
Historically the blood has always been a lovely liquid for humans, however, it was only after great scientific advances in hemotherapy that blood transfusion techniques have become a routine therapy in medical practice with great safety for donors and ...
Lacy C. Brito Junior   +2 more
doaj   +1 more source

Preclinical Evaluation of the Tumorigenic and Immunomodulatory Properties of Human Bone Marrow Mesenchymal Stromal Cell Populations with Clonal Trisomy 5

open access: yesStem Cells International, 2022
Cytogenetic aberrations may emerge in human mesenchymal stromal cells (MSC) during ex vivo expansion for cell therapy. We have detected clonal trisomy 5 in two distinct autologous MSC products expanded from bone marrow which, based on the current quality
Maria Susana Joya Marodin   +11 more
doaj   +1 more source

TO EVALUATE THE PERCEPTION OF NURSING PROFESSIONALS IN THE USE OF A MONITORING INSTRUMENT IN THE HEMOTHERAPY PROCESS IN AN ONCOLOGY HOSPITAL IN THE STATE OF SÃO PAULO

open access: yesHematology, Transfusion and Cell Therapy
Introduction: A specific instrument for monitoring the transfusion process was designed with the aim of managing, monitoring and tracking all stages of the transfusion process, in the Hemotherapy Service of the Cancer Institute of the State of São Paulo (
SRS Lira   +7 more
doaj   +1 more source

Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy

open access: yesFrontiers in Immunology, 2023
BackgroundDonor-specific antibodies (DSAs) are IgG allo-antibodies against mismatched donor HLA molecules and can cause graft failure (GF) in the setting of haploidentical hematopoietic stem cell transplantation (haplo-HSCT).
Rebeca Bailén   +40 more
doaj   +1 more source

Efficacy and Safety of Prophylaxis With a Plasma‐Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease—A WIL‐31 Study Sub‐Analysis

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Objectives The WIL‐31 study demonstrated efficacy and safety of prophylaxis with the plasma‐derived von Willebrand factor/factor VIII concentrate wilate in von Willebrand disease (VWD) of all types and was the only prospective study with an on‐demand run‐in study as an intra‐individual comparator.
Claudia Djambas Khayat   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy